Poster # 2130 A Feasibility Trial of Concurrent Radiation, Temozolomide and Bevacizumab Followed by Temozolomide and Bevacizumab for Resectable and Unresectable Glioblastoma Multiforme of the Brain

Presenter: Robert Liebross, MD

About the Presenter:
Dr. Liebross is an Indiana Licensed, Board Certified Radiation Oncologist. While Dr. Liebross is credentialed at several hospitals within Indiana and specifically the Indianapolis and surrounding areas he currently sees patients at St. Vincent Hospital of Indianapolis and Witham Memorial Hospital in Lebanon. Dr. Liebross graduated from New York University Medical School in 1995. After graduating from Medical School he did an Internship in Internal Medicine through Memorial Sloan-Kettering Cancer Center in New York, New York, and North Shore University Hospital in Manhasset, New York, followed by a Radiation Oncology Residency at The University of Texas through MD Anderson Cancer Center in Houston, Texas completing his program in 2000. Upon the completion of his Residency in 2000, Dr. Liebross worked for Indiana Radiation Oncology, LLC of Indianapolis, Indiana which in May 2008, merged with Cancer Care Group, P.C. During Dr. Liebrossí tenure as a Radiation Oncologist, he has participated in many professional societies and professional committees. Dr. Liebross has also participated and continues to participate in several medical research groups and has been published multiple times.

Abstract:


E-mail a friend about this poster:
Enter email address: